Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China

Chinese Medical Journal

Volumn 121, Issue 16, 2008, Pages 1578-1582

  Zhang, Wen Ying ^a   Xue, Yue Zhen ^a   Chen, Min ^b   Han, Ling ^a   Luo, Man ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Prevalence; Uterine cervical neoplasms; Viral load

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CHINA; COLPOSCOPY; CONDYLOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENITAL SYSTEM EXAMINATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PREVALENCE; PUNCH BIOPSY; RETROSPECTIVE STUDY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CERCLAGE; VIRUS LOAD; WART VIRUS;

EID: 52949142328     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200808020-00015     Document Type: Article

References (23)

1. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-5.
2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81.
3. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
4. Carvalho MO, Carestiato FN, Perdigao PH, Xavier MP, Silva K, Botelho MO, et al. Human papillomavirus infection in Rio de Janeiro, Brazil: a retrospective study. Braz J Infect Dis 2005; 9: 398-404.
5. Huang SL, Liu ZQ, Zhang XN, Li MJ. Human papillomavirus, human cytomegalovirus and oncogene C-myc in cervical carcinoma and cervicitis. Chin Med J 1993; 106: 208-210.
6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995; 87: 796-802.
7. Bory JP, Cucherousset J, Lorenzato M, Gabriel R, Quereux C, Birembaut P, et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3091 women. Int J Cancer 2002; 102: 519-525.
8. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20-25.
9. Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP, et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001; 85: 398-404.
10. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002; 76: 41-47.
11. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study Lancet 2000; 355: 2194-2198.
12. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-coutrol study. Lancet 2000; 355: 2189-2193.
13. Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163: 534-543.
14. Rombaldi RL, Serafini EP, Villa LL, Vanni AC, Barea F, Frassini R, et al. Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia. Braz J Med Biol Res 2006; 39: 177-187.
15. Wang X, Zhu Q, Rao H. Maternal-fetal transmission of human papillomavirus. Chin Med J 1998; 111: 726-727.
16. Moscicki AB EJ, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 2004; 190: 37-45.
17. Jacobson DL, Womack SD, Peralta L, Zenilman JM, Feroli K, Maehr J, et al. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J 2000; 19: 722-728.
18. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004; 189: 46-50.
19. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and youag adult women. J Pediatr 2002; 141: 718-723.
20. Orji EO, Esimai OA. Sexual behaviour and contraceptive use among secondary school students in Ilesha south west Nigeria. J Obstet Gynaecol 2005; 25: 269-272.
21. Curtis SL, Sutherland EG. Measuring sexual behaviour in the era of HIV/ AIDS: the experience of Demographic and Health Surveys and similar enquiries. Sex Transm Infect 2004; 80 Suppl 2: ii22-ii27.
22. Brisson J, Bairati I, Morin C, Fortier M, Bouchard C, Christen A, et al. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis 1996; 173: 794-799.
23. Castle PE, Wacholder S. Sherman ME, Lorincz AT, Glass AG, Scott DR, et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 2002; 95: 2145-2151.